Baxter's Preflucel gets EU OK

Baxter International has received the approval of a European repeat mutual recognition procedure by the Austrian Agency for Health and Food Safety for the Preflucel seasonal influenza vaccine. The 13 participating EU countries, including Germany, Spain, UK and Nordic countries, will formally implement the license on a national level to make Preflucel available for the 2011-12 influenza season. Baxter release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.